Researchers detail groundbreaking Angelman syndrome development
Researchers at Texas A&M University have developed the first molecular therapeutic for Angelman syndrome to advance into clinical development.
Mar 23, 2023
0
150
Researchers at Texas A&M University have developed the first molecular therapeutic for Angelman syndrome to advance into clinical development.
Mar 23, 2023
0
150
In experiments with mice and humans, a team led by Johns Hopkins Medicine researchers says it has identified a particular intestinal immune cell that impacts the gut microbiome, which in turn may affect brain functions linked ...
Mar 20, 2023
0
451
Chagas disease affects approximately 6 million people only in Latin America and is one of the leading causes of death in this region. This infectious disease, also called American trypanosomiasis, is caused by the parasite ...
Mar 8, 2023
0
27
Northwestern Medicine scientists have identified the cause of a genetic subtype of autism and schizophrenia that results in social deficits and seizures in mice and humans.
Feb 28, 2023
0
57
Researchers from the University of Cincinnati examined the post-treatment journals kept by participants in a 2014 smoking cessation study that found psychedelics were effective in helping some people quit smoking for years.
Feb 24, 2023
0
89
Asking patients to take a short survey on a tablet before their appointments may help mental health providers identify young people at risk of psychosis. A UC Davis Health study found that when patients took a 21-question ...
Feb 17, 2023
0
76
When we daydream or revisit memories, a large group of regions within our brain "lights up," or becomes more active. It's referred to as the Default Mode Network (DMN) because it is more active when the brain is not focused ...
Feb 15, 2023
0
107
Targeting calcium signaling in neurons represents a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study published in Biological Psychiatry.
Feb 7, 2023
0
87
An Emory University study published in Molecular Psychiatry shows levodopa, a drug that increases dopamine in the brain, has potential to reverse the effects of inflammation on brain reward circuitry, ultimately improving ...
Jan 27, 2023
0
151
A new Duke University study appears to ease concerns that clergy would steer congregants suffering from depression away from mental health providers and instead rely only on their faith.
Jan 11, 2023
0
29